Results 31 to 40 of about 2,613 (178)

Research priorities for characterising Bundibugyo virus.

Lancet, The
Henry Kyobe Bosa, Patrick D M C Katoto, Kyeng Mercy   +2 more
exaly   +3 more sources

Note contextuelle sur l’épidémie d’Ebola Bundibugyo en Ituri (2026)

Cette note vise à fournir des éléments de contexte sur la province de l’Ituri actuellement affectée par une épidémie d’Ebola Bundibugyo. Elle ne discute pas directement l’actualité immédiate et les derniers développements de la réponse Ebola, mais ...
Park, Sung-Joon, Wema Muhindo, Kennedy, Giles-Vernick, Tamara, Boone, Douglas, Wilkinson, Annie, Vangazi, Christian, Laudisoit, Anne, Vikanza, Paul, Godeschalk, Mark, Chober, Adolphe, Agenonga, James, Myfanwy, Araali, Bagamba, Bedford, Juliet, Lokombe, Pierre, Odimo, Takaibone, Pascal, Macgregor, Hayley, Saez, Almudena, Mari, Marijsse, Simon, Titeca, Kristof, Vlassenroot, Koen, Larochelle, Patrick, Villa, Jules, Amuda, Dieu Merci, Epelboin, Alain, Fahey, Daniel, Duclos, Diane, Pottier, Johan   +26 more
core   +6 more sources

Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008

Emerging Infectious Diseases, 2010
During August 2007–February 2008, the novel Bundibugyo ebolavirus species was identified during an outbreak of Ebola viral hemorrhagic fever in Bundibugyo district, western Uganda.
Joseph F. Wamala, Luswa Lukwago, Mugagga Malimbo, Patrick Nguku, Zabulon Yoti, Monica Musenero, Jackson Amone, William Mbabazi, Miriam Nanyunja, Sam Zaramba, Alex Opio, Julius J. Lutwama, Ambrose O. Talisuna, Sam I. Okware   +13 more
doaj   +1 more source

Cultural Risk Factors to the Outbreak of Ebola Bundibugyo (BDBV) [PDF]

, 2018
This study investigated the risk factors to the outbreak of Ebola Bundibugyo in Bundibugyo district. The research aimed at investigating the different risk factors that led to the outbreak of Ebola Bundibugyo Virus (BDBV) in Bundibugyo district.
Twalibu, Nzanzu, Charles, Twesigye
core   +1 more source

Can the Ebola Zaire vaccine stop the Bundibugyo virus?

South Sudan Medical Journal
Reports indicate that the WHO and Africa CDC approved the DRC government’s request to release Ervebo vaccines for use against the Bundibugyo virus in August.
Edward Kenyi
doaj   +1 more source

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.

PLoS Pathogens, 2008
Over the past 30 years, Zaire and Sudan ebolaviruses have been responsible for large hemorrhagic fever (HF) outbreaks with case fatalities ranging from 53% to 90%, while a third species, Côte d'Ivoire ebolavirus, caused a single non-fatal HF case.
Jonathan S Towner, Tara K Sealy, Marina L Khristova, César G Albariño, Sean Conlan, Serena A Reeder, Phenix-Lan Quan, W Ian Lipkin, Robert Downing, Jordan W Tappero, Samuel Okware, Julius Lutwama, Barnabas Bakamutumaho, John Kayiwa, James A Comer, Pierre E Rollin, Thomas G Ksiazek, Stuart T Nichol   +17 more
doaj   +1 more source

A SOME ECOLOGICAL CHARACTERISTICS OF EBOLA VIRUS IN NATURAL FOCIES

Журнал микробиологии, эпидемиологии и иммунобиологии, 2018
Ebola virus that composed Ebolavirus genus of Filoviridae Family causes severe hemorrhagic fever in humans with high case-fatality rates (up to 90%).
T. E. Sizikova, V. N. Lebedev, N. V. Karulina, O. V. Chukhralya, S. I. Syromyatnikova, S. V. Borisevich   +5 more
doaj   +1 more source

2007, Bundibugyo, Uganda Ebola epidemic data and knowledge

, 2017
Information about the 2007, Bundibugyo, Uganda Ebola epidemic curated from multiple publications and reports. The information is represented in machine-interpretable Apollo-XSD format.
Dato, Virginia (5193904), Dato, Virginia
core   +1 more source

Clock-like behavior across Orthoebolavirus species suggests alternative evolution of the 2026 Bundibugyo virus outbreak

Journal of Infection in Developing Countries
Introduction: Recent increase in reported cases of Bundibugyo virus (species Orthoebolavirus bundibugyoense) in the Democratic Republic of the Congo and Uganda highlight the importance of understanding their evolutionary dynamics.
Gustavo Sganzerla Martinez, Anuj Kumar, Mansi Dutt, Misaki Wayengera, Wilber Sabiiti, David J Kelvin, Henry Kyobe Bosa   +6 more
doaj   +1 more source

Repurposed Medicines for Viruses With Epidemic or Pandemic Potential: A Horizon Scan

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Viruses such as Ebola, Marburg, influenza, mpox, MERS‐CoV, SARS‐CoV, and SARS‐CoV‐2 may be considered pathogens of epidemic or pandemic concern. Developing novel antiviral medicines can be time‐consuming and resource intensive. Repurposing existing medicines with known or potential antiviral activity offers a faster, cost‐effective strategy to
Sola Akinbolade, Rhiannon Potter, Alex Inskip, Jane Nesworthy, Kirsti Brock, Gill Norman   +5 more
wiley   +1 more source